news & events
portfolio news
10.06.13
MedLumics appoints Dr. Wolfgang Reim as Independent Director
14.05.13
TiGenix Business Update & Financial Highlights for Q1 of 2013
13.05.13
Endosense underscores significance of contact force parameters with new study data at heart rhythm 2013
06.05.13
Medical Diagnostics Company STAT-Diagnostica Secures 22.1 Million USD/17 Million Euros in Series B Financing
22.04.13
TiGenix reports positive Phase IIa study results in refractory rheumatoid arthritis with allogeneic stem cell product Cx611
26.03.13
Endosense’s efficas i study yields new contact force guidelines in catheter ablation treatmentof af: findings published in circulation: arrhythmia and electrophysiology
12.03.13
TiGenix to obtain national reimbursement in Spain for its innovative cartilage therapy ChondroCelect®
12.03.13
TiGenix Reports Full Year 2012 Financial Results
05.03.13
Endosense closes an additional USD 4.3 million/CHF 4 million in series C financing
01.02.13
First u.s. case performed with endosense’s tacticath quartz contact-force sensing ablation catheter
